Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

September 6, 2024 William Newton, Associate Editor/Senior Writer Views

Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton